You are here

Proc Natl Acad Sci U S A DOI:10.1073/pnas.0401139101

The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1.

Publication TypeJournal Article
Year of Publication2004
AuthorsColetta, RD, Christensen, K, Reichenberger, KJ, Lamb, J, Micomonaco, D, Huang, L, Wolf, DM, Müller-Tidow, C, Golub, TR, Kawakami, K, Ford, HL
JournalProc Natl Acad Sci U S A
Date Published2004 Apr 27
KeywordsAnimals, Blotting, Western, Breast Neoplasms, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cyclin A, Cyclin A1, Gene Expression Regulation, Neoplastic, Homeodomain Proteins, Humans, Mice, Mice, Nude, Neoplasm Transplantation, Precipitin Tests, Reverse Transcriptase Polymerase Chain Reaction

Homeobox genes constitute a large family of transcription factors that are essential during normal development and are often dysregulated in cancer. However, the molecular mechanisms by which homeobox genes influence cancer remain largely unknown. Here we show that the tissue-restricted cyclin A1 is a transcriptional target of the Six1 homeoprotein. Both genes are expressed in the embryonic but not the terminally differentiated mammary gland, and Six1-knockout mice show a dramatic reduction of cyclin A1 in the embryonic mammary gland. In addition, both genes are reexpressed in breast cancers. Six1 overexpression increases cyclin A1 mRNA levels and activity, cell proliferation, and tumor volume, whereas Six1 down-regulation decreases cyclin A1 mRNA levels and proliferation. Overexpression of Six1 in wild-type mouse embryonic fibroblasts, but not in knockout variants lacking the cyclin A1 gene, induces cell proliferation. Furthermore, inhibition of cyclin A1 in Six1-overexpressing mammary carcinoma cells decreases proliferation. Together these results demonstrate that cyclin A1 is required for the proliferative effect of Six1. We conclude that Six1 overexpression reinstates an embryonic pathway of proliferation in breast cancer by up-regulating cyclin A1.


Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID15123840
PubMed Central IDPMC404070
Grant ListR01 CA095277 / CA / NCI NIH HHS / United States
1R01CA095277-01 / CA / NCI NIH HHS / United States